Relating to required labeling of certain products containing or derived from aborted human fetal tissue.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 4 Sponsors

Feb 3, 2025 · Senate

Read first time

Feb 3, 2025 · Senate

Referred to Health & Human Services

Nov 12, 2024 · Senate

Received by the Secretary of the Senate

Nov 12, 2024 · Senate

Filed

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base In Committee — base rate 11%, measured from TX's completed sessions
Momentum -5 28/100 from the pace of recorded action
Time since last action -22 614 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.